MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

The MEK5-ERK5 pathway is a mammalian mitogen-activated protein (MAP) kinase cascade that is not well studied compared to other MAP kinase cascades. Two independent studies by Al-Ejeh et al. and Ortiz-Ruiz et al. published in Oncotarget last year concluded that ERK5 is an attractive target in triple...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Mariska, Rozali, Esdy, Khanna, Kum Kum, Al-Ejeh, Fares
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381702/
https://www.ncbi.nlm.nih.gov/pubmed/25859552

Ejemplares similares

Ejemplares similares